LOPROX CRM 1% 10 MG — DIN 00593362
CICLOPIROX OLAMINE : 10 MG · HOECHST CANADA INC. · CREAM · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is LOPROX CRM 1%?
LOPROX CRM 1% 10 MG contains CICLOPIROX OLAMINE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 00593362, held by HOECHST CANADA INC., supplied as CREAM for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 29-Aug-1996. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Ciclopirox cost around the world?
Ciclopirox is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Brazil publishes a preco fabrica (ex-factory ceiling); Greece publishes a producer price (ex-factory); Spain publishes a PVP con IVA (public price). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 5 | 27 | USD███.██ |
| Spain | PVP con IVA (public price) | 10 | 10 | EUR███.██ |
| Brazil | preco fabrica (ex-factory ceiling) | 3 | 4 | BRL███.██ |
| Greece | producer price (ex-factory) | 3 | 3 | EUR███.██ |
44 pack listings across 21 brand entries and 4 price bases, refreshed 05 Sep 2026. Ranges span every Ciclopirox pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Ciclopirox in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
8 holders have a Canadian DIN containing Ciclopirox, across 12 DINs, of which 4 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BAUSCH HEALTH, CANADA INC. | 3 | 2 | LOPROX, PENLAC | Sourceable in Canada |
| APOTEX INC | 1 | 1 | APO-CICLOPIROX | Sourceable in Canada |
| TARO PHARMACEUTICALS INC | 1 | 1 | TARO-CICLOPIROX | Sourceable in Canada |
| HOECHST CANADA INC. | 2 | 0 | LOPROX CRM 1%, LOPROX LOTION 1% | No marketed DIN |
| HOECHST ROUSSEL CANADA INC. | 2 | 0 | LOPROX CREAM 1%, LOPROX LOTION 1.0% | No marketed DIN |
| GLAXOSMITHKLINE INC | 1 | 0 | STIEPROX SHAMPOO | No marketed DIN |
| PHARMASCIENCE INC | 1 | 0 | PMS-CICLOPIROX | No marketed DIN |
| STERIMAX INC | 1 | 0 | CICLOPIROX TOPICAL SOLUTION | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 10 MG |
|---|---|
| Dosage form | CREAM |
| Route | TOPICAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Ciclopirox |
|---|---|
| ATC code | D01AE14 |
| AHFS class | 84:04.08.20 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00593362 |
|---|---|
| DIN (unpadded, as printed on some documents) | 593362 |
| Brand name | LOPROX CRM 1% |
| Generic / active ingredient | CICLOPIROX OLAMINE : 10 MG |
| Market authorization holder | HOECHST CANADA INC. |
| Health Canada schedule | Prescription |
| ATC code | D01AE14 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D01AE |
| Current status | CANCELLED POST MARKET |
| Status date | 29-Aug-1996 |
| Original market date | 1985-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
4 of 12 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-CICLOPIROX | 8 % | SOLUTION | APOTEX INC | MARKETED | 02298953 |
| LOPROX | 1 % | CREAM | BAUSCH HEALTH, CANADA INC. | MARKETED | 02221802 |
| LOPROX | 1 % | LOTION | BAUSCH HEALTH, CANADA INC. | MARKETED | 02221810 |
| TARO-CICLOPIROX | 8 % | SOLUTION | TARO PHARMACEUTICALS INC | MARKETED | 02353288 |
| CICLOPIROX TOPICAL SOLUTION | 8 % | SOLUTION | STERIMAX INC | CANCELLED POST MARKET | 02410346 |
| LOPROX CREAM 1% | 10 MG | CREAM | HOECHST ROUSSEL CANADA INC. | CANCELLED POST MARKET | 01987569 |
| LOPROX LOTION 1.0% | 1 % | LOTION | HOECHST ROUSSEL CANADA INC. | CANCELLED POST MARKET | 01989626 |
| LOPROX LOTION 1% | 10 MG | LOTION | HOECHST CANADA INC. | CANCELLED POST MARKET | 00836281 |
| PENLAC | 8 % | SOLUTION | BAUSCH HEALTH, CANADA INC. | DORMANT | 02250535 |
| PMS-CICLOPIROX | 8 % | SOLUTION | PHARMASCIENCE INC | CANCELLED POST MARKET | 02413574 |
2 · Same class — other molecules in ATC D01AE
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Tolnaftate | ABSORBINE ANTIFUNGAL POWDER 1% · ABSORBINE JR ANTIFUNGAL LIQ · ABSORBINE JR ANTIFUNGAL LIQUID · ANTIFUNGAL ATHLETE'S FOOT POWDER SPRAY · +48 more | 52 | 11 | Yes |
| Ciclopirox | APO-CICLOPIROX · CICLOPIROX TOPICAL SOLUTION · LOPROX · LOPROX CREAM 1% · +7 more | 12 | 4 | Yes |
| Terbinafine | LAMISIL · LAMISIL DERMGEL · PMS-TERBINAFINE CREAM · PMS-TERBINAFINE SPRAY | 5 | 2 | Yes |
| Undecylenic Acid | CRUEX ANTIFUNGAL CREAM · CRUEX MEDICATED PWR 10% · CRUEX MEDICATED SPRAY POWDER · DESENEX ANTIFUNGAL POWDER · +6 more | 10 | 0 | Not in Canada |
| Chlorphenesin | MYCIL CREAM · MYCIL CREAM 1% · MYCIL POWDER · MYCIL POWDER 1% | 4 | 0 | Not in Canada |
| Butenafine | DR. SCHOLL'S ATHLETE'S FOOT CREAM · TINACTIN ONCE-A-DAY CREAM | 3 | 0 | Not in Canada |
| Naftifine | NAFTIN CRM 1% · NAFTIN GEL 1% | 2 | 0 | Not in Canada |
| Combinations | BRITISH ARMY FOOT PWR · TRIPLE DYE | 2 | 0 | Not in Canada |
| Methylrosaniline | GENTIANE VIOLET LIQ TOP | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D01AC | Clotrimazole · Econazole · Efinaconazole · Imidazoles/Triazoles In Combination With Corticosteroids · Ketoconazole · +3 more | 31 | 12 |
| D01AA | Nystatin | 12 | 1 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is LOPROX CRM 1% called?
The same molecule, Ciclopirox, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| MICOLAMINA | Latin | Brazil |
| CICLOPIROX OLAMINA | Latin | Brazil |
| LAKESIAMEDICAL | Latin | Brazil |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.